PBAC Public Summary Documents - November 2014

Page last updated: 8 March 2018

Public Summary Documents relating to the November 2014 PBAC meeting.

• Adalimumab; 20 mg/0.4 ml injection, 2 x 0.4 ml syringes, 40 mg/0.8 ml injection, 2 x 0.8 ml cartridges, 40 mg/0.8 ml injection, 2 x 0.8 ml syringes, 40 mg/0.8 ml injection, 6 x 0.8 ml cartridges, 40 mg/0.8 ml injection, 6 x 0.8 ml syringes; Humira®
• Aflibercept; 4 mg/0.1 mL injection, 1 x 0.1 mL vial, 4 mg/0.1 mL injection, 1 x 0.09 mL syringe; Eylea® (DME)
• Aflibercept; 4 mg/0.1 mL injection, 1 x 0.1 mL vial, 4 mg/0.1 mL injection, 1 x 0.09 mL syringe; Eylea® (CRVO)
• Alemtuzumab; solution for infusion, 10 mg/ mL; Lemtrada®
• Amino acid formula with vitamins and minerals without phenylalanine; oral liquid, 30 x 130 mL & 30 x 174 mL pouch; PKU Air®
• Amino acid formula with vitamins and minerals without phenylalanine; oral liquid: powder for, 30 x 36 g sachets; PKU Anamix Junior®
• Amino acid formula with vitamins and minerals without phenylalanine and tyrosine; oral liquid: powder for, 30 x 36 g sachets, TYR Anamix Junior®
• Amino acid formula with vitamins and minerals without valine, leucine and isoleucine; oral liquid: powder for, 30 x 36 g sachets; MSUD Anamix Junior®
• Anakinra; 100 mg/0.67 mL, 28 X 0.67 mL syringes; Kineret®
• Anastrozole; everolimus; exemestane; goserelin; letrozole
• Apomorphine; Injection, 10 mg in 1 mL, Apomine®
• Axitinib; tablets, 1 mg & 5 mg; Inlyta®
• Buprenorphine + naloxone; 4mg/1mg film: sublingual, 12mg/3mg film: sublingual, Suboxone®
• Capecitabine; megestrol; toremifene; vinorelbine
• Certolizumab pegol; 200 mg/mL injection, 2 x 1 mL syringes; Cimzia®
• Cetuximab; solution for intravenous (IV) infusion, 100 mg in 20 mL & 500 mg in 100 mL; Erbitux®
• Coal tar prepared; 2% (20 mg/g), foam aerosol, 100 g; Scytera® Foam
• Crizotinib; 200 mg capsule, 60 and 250 mg capsule, 60; Xalkori®
• Dapagliflozin; tablet, 10 mg; Forxiga®
• Diphtheria + tetanus + acellular pertussis (DTPa) vaccine; Infanrix®
• Dolutegravir + abacavir + lamivudine; dolutegravir 50 mg + abacavir 600 mg + lamivudine 300 mg tablet, 30; Triumeq®
• Elosulfase alfa; 1 mg/mL concentrate for solution for infusion, 5mL vial; Vimizim®
• Eltrombopag; tablets, 25 mg and 50 mg; Revolade®
• Enoxaparin sodium; 20 mg/0.2 mL injection, 10 x 0.2 mL pre-filled syringes, 40 mg/0.4 mL injection, 10 x 0.4 mL pre-filled syringes, 60 mg/0.6 mL injection, 10 x 0.6 mL pre-filled syringes, 80 mg/0.8 mL injection, 10 x 0.8 mL pre-filled syringes, 100 mg/1.0 mL injection, 10 x 1.0 mL pre-filled syringes; Clexane Safety-Lock®
• Ezetimibe + atorvastatin; fixed dose combination tablets, 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg and 10 mg/80 mg; Atozet®
• Ezetimibe + simvastatin; tablets, 10 mg – 10 mg, 10 mg – 20 mg, 10 mg – 40 mg and 10 mg – 80 mg; Vytorin®
• Glucose indicator blood strip; diagnostic, 100; Dario® Blood Glucose Test Strip
• Glucose indicator blood strip; diagnostic, 50 and 100; GluNeo® Blood Glucose Test Strip, Healthpro® Blood Glucose Test Strip
• Iron chelating agents; Deferasirox, Deferiprone, Desferrioxamine
• Iron sucrose; 100 mg/5 mL injection, 5 x 5 mL ampoules; Venofer®
• Itraconazole; 50 mg capsule, 60; Lozanoc®
• Ivacaftor; tablet, 150 mg; Kalydeco®
• Leuprorelin; 30 mg injection: modified release [1 x 30 mg syringe] (&) inert substance diluent [1 x 2 ml syringe], 1 pack; Lucrin Depot Paediatric®
• Mercaptopurine; oral suspension 20 mg/mL, 100 mL; Allmercap®
• Mesalazine; 3 g granules: modified release, 30 sachets; Salofalk®
• Mesalazine; 4 g granules: modified release, 30 x 4 sachets; Pentasa®
• Nitisinone; 2 mg capsule, 60, 5 mg capsule, 60, 10 mg capsule, 60; Orfadin®
• Ocriplasmin; 0.5 mg / 0.2 mL injection, 1 x 0.2 mL vial, Jetrea®
• Ocular lubricants
• Ofatumumab; 100 mg/5 mL injection, 5 mL vial, 1 g/50 mL injection, 50 mL vial; Arzerra®
• Omalizumab; 75 mg/0.5 mL injection, 1 x 0.5 mL syringe, 150 mg/mL injection, 1 x 1 mL syringe, 150 mg injection [1 x 150 mg vial] (&) inert substance diluent [1 x 1.2 mL ampoule], 1 pack; Xolair®
• Oxycodone; modified release tablets, 10mg, 15mg, 20mg, 30mg, 40mg, 80mg, OxyContin®
• Paracetamol; tablet (modified release), 665 mg; Paracetamol Osteo- Tab®
• Peginterferon beta-1a; 63 microgram/0.5 ml injection, 0.5 ml syringe + 94 microgram/0.5 ml injection, 0.5 ml syringe, 63 microgram/0.5 ml injection, 0.5 ml injection device + 94 microgram/0.5 ml injection, 0.5 ml injection device, 125 microgram/0.5 ml injection, 2 x 0.5 ml syringes, 125 microgram/0.5 ml injection, 2 x 0.5 ml injection devices; Plegridy®
• Pertuzumab; 420 mg/14 mL injection, 1 x 14 mL vial; Perjeta®; Trastuzumab; 150 mg injection, 1 × 150 mg vial, 60 mg injection, 1 × 60 mg vial; Herceptin®; Trastuzumab emtansine; 100 mg injection, 1 x 100 mg vial, 160 mg injection, 1 x 160 mg vial;Kadcyla®
• Pomalidomide; capsules, 3 mg and 4 mg; Pomalyst®
• Ponatinib; tablets; 15 mg and 45 mg; Iclusig®
• Ranibizumab; 2.3 mg/0.23 mL, 1 x 0.23 mL vial, 1.65 mg/0.165 mL, pre-filled syringe; Lucentis®
• Rituximab; 1,400 mg/11.7 mL; solution for subcutaneous injection; Mabthera® SC
• Salbutamol; 200 microgram inhalation: powder for, 128 capsules; Ventolin® Rotacaps®
• Sorafenib; tablet, 200 mg; Nexavar®
• Sucroferric oxyhydroxide; Iron (as sucroferric oxyhydroxide) 500 mg tablet: chewable, 90; Velphoro®
• Riociguat; tablets; 0.5 mg, 1 mg, 1.5 mg and 2 mg; Adempas®
• Taliglucerase alfa; powder for IV infusion, 200 units; Elelyso®
• Trametinib; 500 microgram tablet 30, 2 mg tablet 30; Mekinist®
• Umeclidinium + vilanterol; umeclidinium (as bromide) 62.5 microgram/actuation + vilanterol (as trifenatate) 25 microgram/actuation, inhalation: powder for, 30 actuations; Anoro® Ellipta®
• Ustekinumab; 45 mg/0.5 mL injection, 1 x 0.5 mL vial; Stelara®
• Zoster virus vaccine live; 0.65 mL injection, prefilled syringe; Zostavax®